Find clinical trials for Pancreatic Cancer in Sevilla, AN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Sevilla, AN, ESP:
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...
Phase 2
Sevilla, Andalucia, Spain and 16 other locations
Phase 1b/2 study to assess the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic du...
Phase 1, Phase 2
Sevilla, Spain and 15 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Sevilla, Spain and 91 other locations
This research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer age...
Phase 1, Phase 2
Sevilla, Spain and 71 other locations
efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recur...
Phase 1, Phase 2
Sevilla, Spain and 30 other locations
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor...
Phase 1
Sevilla, Spain and 63 other locations
This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors that harbor...
Phase 2
Sevilla, Spain and 122 other locations
To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...
Phase 2
Sevilla, Spain and 90 other locations
in participants with advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC), pancreatic duct adenocarcinoma (PDAC), biliary t...
Phase 1, Phase 2
Sevilla, Spain and 31 other locations
To evaluate the safety and anti-tumor activity of GEN1042 in patients with metastatic or locally advanced solid tumors.
Phase 1, Phase 2
Sevilla, Spain and 75 other locations
Clinical trials
Research sites
Resources
Legal